Khiron Life Sciences Corp. (KHRNF) Research

Khiron Life Sciences Corp. operates as a comprehensive medical and cannabis enterprise, extending its operations across Latin America and Europe. The company's business is structured into three primary segments: Health Services, Medical Cannabis Products, and Wellbeing Products. A core focus for Khiron involves the end-to-end process of medical cannabis, encompassing the cultivation, manufacturing, distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) varieties. Additionally, the company manages a network of health centers and satellite clinics, notably under the ILANS and Zerenia brands. It also develops CBD-based cosmeceutical items, specifically marketed under its Kuida brand. Its healthcare footprint includes running Zerenia clinics in key locations such as Medellin and Peru. Khiron Life Sciences Corp. was founded in 2012 and maintains its corporate headquarters in Vancouver, Canada.

Market snapshot

Symbol
KHRNF
Price
$0.00
Day change
0.00%
Market cap
$9.3M
P/E ratio
-0.20x
52-week range
0.000001-0.00001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Peer companies

  • Aion Therapeutic Inc. (ANTCF)
  • Bespoke Extracts, Inc. (BSPK)
  • EVIO, Inc. (EVIO)
  • Genix Pharmaceuticals Corporation (GENPF)
  • Hemp, Inc (HEMP)
  • Kaya Holdings, Inc. (KAYS)
  • Resonate Blends, Inc. (KOAN)
  • CordovaCann Corp. (LVRLF)

Open Khiron Life Sciences Corp. (KHRNF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.